Cytokines Link Toll-Like Receptor 4 Signaling to Cardiac Dysfunction After Global Myocardial Ischemia

Annals of Thoracic Surgery

Volumn 85, Issue 5, 2008, Pages 1678-1685

  Cha, John ^a   Wang, Zhiping ^b   Ao, Lihua ^a   Zou, Ning ^c   Dinarello, Charles A ^a   Banerjee, Anirban ^a   Fullerton, David A ^a   Meng, Xianzhong ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART DISEASE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; GENE EXPRESSION; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42949110583     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.01.043     Document Type: Article

References (34)

1. Meldrum D.R., Meng X., Dinarello C.A., et al. Human myocardial tissue TNFα expression following acute global ischemia in vivo. J Mol Cell Cardiol 30 (1998) 1683-1689
2. Cain B.S., Meldrum D.R., Dinarello C.A., et al. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 27 (1999) 1309-1318
3. Tomasdottir H., Hjartarson H., Ricksten A., Wasslavik C., Bengtsson A., and Ricksten S.E. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 97 (2003) 944-949
4. Meng X., Ao L., Song Y., Raeburn C.D., Fullerton D.A., and Harken A.H. Signaling for myocardial depression in hemorrhagic shock: roles of Toll-like receptor 4 and p55 TNF-alpha receptor. Am J Physiol Regul Integr Comp Physiol 288 (2005) R600-R606
5. Zhai Y., Shen X.D., O'Connell R., et al. TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173 (2004) 7115-7119
6. Caso J.R., Pradillo J.M., Hurtado O., Lorenzo P., Moro M.A., and Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115 (2007) 1599-1608
7. Chong A.J., Shimamoto A., Hampton C.R., et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128 (2004) 170-179
8. Shimamoto A., Chong A.J., Yada M., et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114 (2006) I270-I274
9. Oyama J., Blais Jr. C., Liu X., et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109 (2004) 784-789
10. Stapel H., Kim S.C., Osterkamp S., et al. Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: Role of matrix metalloproteinases. Eur J Heart Fail 8 (2006) 665-672
11. Gurevitch J., Frolkis I., Yuhas Y., et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 30 (1997) 1554-1561
12. Meldrum D.R., Dinarello C.A., Shames B.D., et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-α production: potential ultimate effector mechanism of preconditioning. Circulation 98 (1998) II214-II219
13. Wan S., DeSmet J.M., Barvais L., Goldstein M., Vincent J.L., and LeClerc J.L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112 (1996) 806-811
14. Deten A., Volz H.C., Briest W., and Zimmer H.G. Differential cytokine expression in myocytes and non-myocytes after myocardial infaction in rats. Mol Cell Biochem 242 (2003) 47-55
15. Chandrasekar B., Colston J.T., and Freeman G.L. Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischemia. Clin Exp Immunol 108 (1997) 346-351
16. Meldrum D.R., Cleveland J.C., Cain B.S., Meng X., and Harken A.H. Increased myocardial tumor necrosis factor-α in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 65 (1998) 439-443
17. Shames B.D., Barton H.H., Reznikov L.L., et al. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock 17 (2002) 114-119
18. Kurrelmeyer K.M., Michael L.H., Baumgarten G., et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 97 (2000) 5456-5461
19. Pomerantz B.J., Reznikov L.L., Harken A.H., and Dinarello C.A. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci U S A 98 (2001) 2871-2876
20. Fantuzzi G., Zheng H., Faggioni R., et al. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 157 (1996) 291-296
21. Ao L., Song Y., Fullerton D.A., Dinarello C.A., and Meng X. The interaction between myocardial depressant factors in endotoxemic cardiac dysfunction: Role of TNF-alpha in TLR4-mediated ICAM-1 expression. Cytokine 38 (2007) 124-129
22. Meng X., Ao L., Meldrum D.R., et al. TNF-α and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol 275 (1998) R502-R508
23. Shames B.D., Meldrum D.R., Selzman C.H., et al. Increased levels of myocardial IkB-α protein promotes tolerance to endotoxin. Am J Physiol 275 (1998) H1084-H1091
24. Rosenau C., Emery D., Kaboord B., and Qoronfleh M.W. Development of a high-throughput plate-based chemiluminescent transcription factor assay. J Biomol Screen 9 (2004) 334-342
25. Appleyard R.F., and Cohn L.H. Myocardial stunning and reperfusion injury in cardiac surgery. J Card Surg 8 2 suppl (1993) 316-324
26. Lüss H., Schäfers M., Neumann J., et al. Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc Res 56 (2002) 411-421
27. Pagani F.D., Baker L.S., Hsi C., et al. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 90 (1992) 389-398
28. Raeburn C., Dinarello C.A., Zimmerman M.A., et al. Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol 283 (2002) H650-H657
29. Casey W.F., Hauser G.J., Hannallah R.S., Midgley F.M., and Khan W.N. Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 20 (1992) 1090-1096
30. Okamura Y., Watari M., Jerud E.S., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276 (2001) 10229-10233
31. Park J.S., Gamboni-Robertson F., He Q., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290 (2006) C917-C924
32. Ohashi K., Burkart V., Flohe S., and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164 (2000) 558-561
33. Asea A., Rehli M., Kabingu E., et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277 (2002) 15028-15034
34. Dybdahl B., Wahba A., Lien E., et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 105 (2002) 685-690